Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
obinutuzumab
×
Clear all
Filters
2
NCT05326308
2025-09-23
ARIADNE
iOMEDICO AG
Recruiting
705 enrolled
NCT02962401
2023-08-29
RemodelWM3
French Innovative Leukemia Organisation
Phase 2
Completed
50 enrolled
NCT03679455
2018-11-13
OBI-1
Polish Myeloma Consortium
Phase 2
Unknown
30 enrolled